Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
4.15B
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
3.37M
-
Shares change
-
-88.1K
-
Total reported value, excl. options
-
$56.8M
-
Value change
-
-$1.5M
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$16.85
Significant Holders of GSK plc - Common Stock as of Q4 2024
3 filings reported holding G3910J179 - GSK plc - Common Stock as of Q4 2024.
GSK plc - Common Stock has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.37M shares
of 4.15B outstanding shares and own 0.08% of the company stock.
Largest 3 shareholders include Aristotle Capital Management, LLC (3.37M shares), Vermillion & White Wealth Management Group, LLC (6 shares), and Eagle Bay Advisors LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.